Intercept’s failed NASH candidate precipitated Alfasigma acquisition by Technical Terrence Team 09/30/2023 0 Mohammed Hanefa Nizamudeen After the Following the failure of Intercept Pharmaceuticals' (ICPT) Ocaliva (obeticholic acid) for nonalcoholic steatohepatitis (NASH) in ...
UC Berkeley and Microsoft Research Redefine Visual Understanding: How Upscaling Outperforms Larger Models Efficiently and Elegantly 03/23/2024